At-home sampling to prevent anal cancer
Part of Cancer, Digestive system clinical trials.
This study tests whether having people collect their own anal samples at home can help find and treat early signs of anal cancer. It is for men and transgender women who have sex with men and who live in or near Chicago, Houston, or Milwaukee.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 35 or older if you have HIV, or 45 or older if you do not have HIV.
- You are a gay, bisexual, or other man who has sex with men, or a transgender woman who has sex with men.
- You live in the Chicago, Houston, or Milwaukee area.
- You are willing to come to a study clinic.
- You speak English or Spanish.
- You are not taking blood thinners other than aspirin or ibuprofen, and you do not have certain bleeding disorders or severe anal conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial checks whether tumor samples contain HPV DNA (genetic material from the HPV virus). The goal is to improve detection in anal and cervical cancers, especially in patients planning standard radiation treatment.
This study tests a self-collected anal swab for detecting HPV (the virus that can cause anal cancer) in people living with HIV. It aims to see if this simple swab is as accurate as a doctor-collected sample, and may help prevent anal cancer.
This study is testing a new way to screen for anal cancer by looking at DNA methylation in cells collected from the anus. It may help people at higher risk for anal cancer find out earlier if they need further tests.
This study is screening gay and bisexual men for anal cancer by taking a swab sample. It aims to find early signs of cancer so it can be treated early.
This study tests how well a special HPV test (called BD Onclarity™) can find anal cancer or precancer. It is for people at high risk or with known anal abnormalities, and aims to improve early detection.
This trial tests whether adding an immunotherapy drug (retifanlimab) to standard chemoradiation improves outcomes for people with locally advanced anal cancer. The treatment is adjusted based on HPV DNA levels in your blood.
Hear when a new Anal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.